Public Employees Retirement System Of Ohio Adagio Therapeutics, Inc. Transaction History

Public Employees Retirement System Of Ohio

$22.6 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Dec 19, 2023	BUY	$3.08 - $4.05 $28,449 - $37,409	9,237 New	9,237 $30,000
Q4 2022 Feb 15, 2023	SELL	$3.08 - $4.05 $6,455 - $8,488	-2,096 Reduced 18.49%	9,237 $14,000
Q3 2022 Nov 15, 2022	BUY	$2.97 - $4.83 $33,659 - $54,738	11,333 New	11,333 $35,000

Others Institutions Holding ADGI

# of Institutions

Shares Held

63.9M

Call Options Held

2.3K

Put Options Held

2.1K

Lee Ainslie Maverick Capital LTD | Dallas, Tx

11.8M
Shares

$38.9 Million
0.81% of portfolio
Deep Track Capital, LP Greenwich, CT

11M
Shares

$36.3 Million
1.34% of portfolio
M28 Capital Management LP Stamford, CT

9.25M
Shares

$30.6 Million
29.1% of portfolio
Black Rock Inc. New York, NY

4.47M
Shares

$14.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.37M
Shares

$14.5 Million
0.0% of portfolio

View Full List

About Adagio Therapeutics, Inc.

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

More about ADGI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account